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This experiment tested the hypothesis that perceived self-inefficacy in exercising control over cogni- 
tive stressors activates endogenous opioid systems. Subjects performed mathematical operations un- 
der conditions in which they could exercise full control over the cognitive task demands or in which 
the cognitive demands strained or exceeded their cognitive capabilities. Subjects with induced high 
perceived self-efficacy exhibited little stress, whereas those with induced low perceived self-efficacy 
experienced a high level of stress and autonomic arousal. Subjects were then administered either an 
inert saline solution or naloxone, an opiate antagonist that blocks the analgesic effects of endogenous 
opiates, whereupon their level of pain tolerance was measured. The self-efficacious nonstressed sub- 
jects gave no evidence of opioid activation. The self-inefficacious stressed subjects were able to with- 
stand increasing amounts of pain stimulation under saline conditions. However, when endogenous 
opioid mechanisms that control pain were blocked by naloxone, the subjects were unable to bear 
much pain stimulation. This pattern of changes suggests that the stress-induced analgesia found 
under the saline condition was mediated by endogenous opioid mechanisms and counteracted by 
the opiate antagonist. 
There is a growing body of evidence that the ability to exer- 
cise control over potential stressors is a critical factor in the acti- 
vation of  different neurophysiological systems. Exposure to 
stressors without controlling efficacy activates neurotransmit- 
ters, stress-related hormones, and impairs various cellular com- 
ponents of  the immune function (Bandura, Taylor, Williams, 
Mefford, & Barchas, 1985; Coe & Levine, in press; Maier, 
Laudenslager, & Ryan, 1985). Exposure to the same stressful 
events with controlling efficacy has few neurochemical effects. 
These findings are based mainly on experimentation with ani- 
mals involving uncontrollable physical stressors. 
Stressors take diverse forms and can produce different pat- 
terns of  physiological activation. This places certain limitations 
on extrapolation of  conclusions across species and stressors. Re- 
search into the neurochemical effects of  inefficacious control 
therefore needs to be broadened and extended to events and 
psychological processes that have high ecological relevance to 
human coping. Uncontrollable physical stressors are not only 
stressful, but also inflict some physical t rauma that can activate 
a variety of  complicating physiological processes. Most of  the 
important stressors with which humans have to cope involve 
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psychological ones that relate to the strain of task demands and 
workloads. It is the perception of demands as exceeding capabil- 
ities that becomes the stressful reality. Efforts to determine the 
neurochemical effects of  inefficacious control in humans have 
relied extensively on correlational or quasi-experimental stud- 
ies in which occurrences of  life stressors are related to indexes 
of  neurophysiological functioning. Although these lines of  re- 
search have clarified some aspects of  inefficacious control, ex- 
perimental studies are needed to verify the direction of  
causality. 
It is generally acknowledged that inefficacious control pro- 
duces neurochemical changes by creating a state of  stress. Psy- 
chological stress is the result of  a relational condition in which 
perceived environmental demands strain or exceed perceived 
coping capabilities in domains of  personal import. People's 
judgments of their controlling efficacy figure prominently in 
their relational appraisal of  demands to capabilities. Perceived 
self-efficacy is concerned with beliefs in one's capabilities to 
mobilize the motivation, cognitive resources, and courses of  ac- 
tion needed to meet given situational demands. 
Findings of  different lines of  research underscore the influ- 
ential role of  perceived control in stress reactions (Averill, 1973; 
Lazarus & Folkman, 1984; Miller, 1980). A sense of  controlla- 
bility can be achieved either behaviorally or cognitively. In be- 
havioral control, individuals take action that forestalls or atten- 
uates environmental stressors. In cognitive control, people op- 
erate under the belief that they can manage such stressors 
should they arise. Although these two forms of  controllability 
are distinguishable operationally, human coping under life cir- 
cumstances rarely involves controlling action devoid of  any 
perceptions of personal control, or perceptions of  personal con- 
trol devoid of any actions. Self-efficacious thought and actions 
are usually products of  reciprocal causation (Bandura, 1986). 
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Being able to exercise control over potential stressors can di- 
minish stress because the capability is used to reduce or to pre- 
vent aversive experiences. But there is much more to the process 
of  stress reduction by behavioral control than simply the mo- 
mentary curtailing of aversive events. Behavioral control instills 
and strengthens beliefs concerning one's coping efficacy. These 
cognitive changes serve as proximal determinants of anticipa- 
tory stress reactions and level of stress during encounters with 
stressors (Bandura, 1988). Thus, in some studies of controllabil- 
ity, merely the exercise of personal control over the occurrence 
of  aversive events without curtailing their intensity reduces 
stress reactions (Gunnar-vonGnechten, 1978). Repeated fail- 
ures create stress reactions when ascribed to personal incapabil- 
ity, but the same failure experiences leave people unperturbed 
if ascribed to situational factors (Wortman, Panciera, Shuster- 
man, & Hibscher, 1976). In situations in which the opportunity 
to wield control exists but is unexercised, it is the self-knowl- 
edge that one can exercise control should one choose to do so 
rather than its application that reduces stress reactions (Glass, 
Reim, & Singer, 1971). These types of findings indicate that 
much of  the stress reductive effects of  behavioral control result 
anticipatorily from perceived capability to wield control over 
troublesome events rather than simply from attenuating them. 
Perceived control without the actuality has been shown to 
reduce stress reactions. People who are led to believe they can 
exercise some control over aversive events display lower auto- 
nomic arousal and less impairment in performance than do 
those who believe they lack personal control, even though they 
are equally subjected to the painful stimuli (Geer, Davison, & 
Gatchel, 1970; Glass, Singer, Leonard, Krantz, & Cummings, 
1973). The foregoing studies have relied on plausible presump- 
tive mediation inferred from the manipulations rather than on 
direct assessment of  perceived self-efficacy and its linkage to 
level of  stress reactions. 
As already alluded to, in social cognitive theory perceived 
self-efficacy operates as a cognitive mechanism through which 
controllability affects stress reactions (Bandura, 1986). If people 
believe they can deal effectively with potential stressors, they are 
not perturbed by them. But if they believe they cannot control 
aversive circumstances, they have much cause for distress. They 
tend to dwell on their coping deficiencies and see the environ- 
ment as fraught with threats. In so doing, they distress them- 
selves and constrain and impair their level of  functioning (Beck, 
Emery, & Greenberg, 1985; Lazarus & Folkman, 1984; Meich- 
enbaum, 1977; Sarason, 1975). Perceived self-inefficacy to con- 
trol perturbing cognitions further augments stress reactions 
(Kent & Gibbons, 1987). 
The microrelation of perceived inefficacy to stress reactions 
has been examined most extensively in coping with phobic 
stressors (Bandura, O'Leary, Taylor, Gauthier, & Gossard, 
1987; Bandura, Reese, & Adams, 1982). Phobics display little 
stress on tasks for which they judge themselves fully efficacious. 
As they cope with tasks for which they distrust their coping 
efficacy, however, their subjective distress mounts, their heart 
rate accelerates, their blood pressure rises, and they display ele- 
vated catecholamine secretion. After their perceived coping 
efficacy is fully strengthened, they manage the same stressors 
with little stress or physiological activation. Thus, the combined 
results from different manifestations of  stress are consistent in 
showing that stress reactions to coping tasks differ when per- 
ceived self-efficacy differs, but reactions to the identical tasks 
are the same when perceived self-efficacy is raised to the same 
maximal level. 
Studies with animals subjected to painful stimulation show 
that stress can activate endogenous opioids that block pain 
transmission (Kelley, 1986). Opioid involvement is indicated 
by evidence that stress-induced analgesia is reduced by opiate 
antagonists, such as nal0xone. It is not the physically painful 
stimulation per se but the psychological stress over its uncon- 
trollability that seems to be a key factor in opioid activation 
(Maier, 1986). Animals who can turn off shock stimulation 
show no opioid activation, whereas yoked animals who experi- 
ence the same shock stimulation without being able to control 
its offset give evidence of  stress-activated opioids. Of the differ- 
ent functions of  endogenous opioids, their pain-relieving effects 
have received greatest attention. However, endogenous opioids 
have a broader adaptive function. By blunting the aversive im- 
pact of stressors, they enable individuals to deal more effectively 
with distressing environmental events. 
The purpose of the present study was to determine whether 
perceived inefficacy in exercising control over cognitive stres- 
sors activates endogenous opioid systems. Subjects performed 
mathematical operations under conditions in which they could 
exercise full control over the cognitive task demands or in which 
the cognitive demands strained or exceeded their cognitive ca- 
pabilities. Changes in subjects' perceived mathematical self- 
efficacy, their level of autonomic arousal during the cognitive 
stressor task, and their subjective distress, mental strain, and 
perceived performance impairment were measured. Following 
induction of high and low levels of  perceived mathematical self- 
efficacy, subjects at each level of  self-efficacy were administered 
either an inert saline solution or an opiate antagonist, naloxone. 
Their level of pain tolerance was then measured at periodic in- 
tervals. 
Perceived controlling inefficacy was expected to be accompa- 
nied by high stress reactions. We hypothesized that self-ineffi- 
cacious stressed subjects would be able to withstand increased 
amounts of  pain stimulation because of the analgesic effects of  
opioid activation. However, they would be unable to bear much 
pain stimulation when the endogenous opioid mechanisms that 
control pain were blocked by naloxone. In contrast, we pre- 
dicted that the self-efficacious nonstressed subjects would dis- 
play no significant changes in pain tolerance under either saline 
or naloxone conditions. 
Method  
Subjects 
Twelve male and 28 female paid volunteers from a college population 
participated in the study. They were randomly assigned to conditions, 
balanced for sex, with 10 subjects in each of four conditions. Subjects 
were selected whose pain tolerance on a cold-pressor test fell within the 
tolerance range, above 20 s at the lower limit and below 180 s at the 
upper limit. These screening criteria were used to avoid ceiling and 
basement effects. The mean pretest pain tolerance was 69 s. Subjects 
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thus had ample latitude to exhibit reductions or increases in pain toler- 
ance. 
The study was presented to subjects as being concerned with the 
effects of intermittent pain on level of cognitive functioning. 
Heart Rate Recording 
After signing the consent form, subjects were outfitted with a Vitalog 
recording device to provide a continuous measure of heart rate during 
the cognitive stressor task. The Vitalng is a miniature microcomputer 
that continuously records heart rate from three chest electrodes into a 
microchip contained in a small unit attached to the subject's waist. The 
Vitalog stores total heart rate per minute. Heart rate was used as a physi- 
olngical indicant of the stressfuiness of the task under differential levels 
of perceived control. 
Perceived Self-Efficacy to Manage Pain 
Self-efficacy scales were devised to measure perceived self-efficacy to 
withstand pain and perceived self-efficacy to reduce its intensity. In 
judging their perceived efficacy to tolerate pain, subjects were presented 
with 20 items representing increasing lengths of cold-pressor stimula- 
tion, ranging from 15 s to 5 rain. The items in the scale measuring pain- 
reduction efficacy described four severities of pain ranging from dull 
to excruciating and, for each severity, three degrees of pain reduction, 
namely small, moderate, or large reductions. Subjects checked the items 
they judged they could perform at that time. For each item checked, 
they rated the strength of their perceived self-efficacy on a 100-point 
scale, ranging in 10-unit intervals from high uncertainty, through inter- 
mediate levels of certainty, to complete certitude. 
Prior research has shown that recording perceived self-efficacy to con- 
trol pain has no reactive effects on pain tolerance (Reese, 1983). The 
measures of strength of perceived self-efficacy to cope with pain were 
obtained by dividing the summed magnitude scores by the total number 
of items. The self-efficacy scales were administered before and after 
each test of pain tolerance. 
ated the appropriate computer program for each subject by entering 
into the subjects' keyboard a preassigned code, and then promptly left 
the room. The code determined which efficacy induction condition sub- 
jects would receive and to whom they would be yoked. For subjects in 
the low controlling efficacy condition, the program presented the same 
number of mathematical problems as had been attempted by their 
counterparts in the high controlling efficacy condition to whom they 
had been randomly yoked. Thus, each pair of yoked subjects was pre- 
sented with the same number of mathematical problems in the identical 
order, and the conditions differed only in the degree to which subjects 
could exercise control over the cognitive task demands. The codes were 
predetermined by a coder who was not associated with the conduct of 
the experiment. This coding procedure ensured that the experimenter 
had no knowledge of the conditions to which subjects had been as- 
signed, as the computer automatically branched to the appropriate 
stimulus presentation on the basis of the coded information. 
The mathematical problems required subjects to perform sequen- 
tially a series of cognitive operations on three integers to arrive at a 
solution (e.g., 73 - 15 • 3). The task was described as a test of basic 
cognitive-processing capabilities. Subjects were presented with the 
mathematical problems continuously over a period of 18 rain. They 
were told that their performance would be assessed as a function of both 
speed and accuracy. To enhance personal involvement in the task, they 
were further informed that, at the end of the session, they would com- 
pare their cognitive processing attainments with those of others who 
had performed the computational activity. 
Subjects in the high self-efficacy condition could exercise full control 
over the cognitive task demands because they regulated the pace of the 
task. Problems appeared on the monitor one at a time and remained 
there until subjects pressed the key for the next mathematical problem. 
The yoked subjects in the low self-efficacy condition were presented 
the same problems in the same order as their high efficacy counterparts, 
but at a pace that exceeded their cognitive capabilities. The pace was set 
on the basis of pretest evidence of the minimal time required to perform 
the necessary cognitive operations. To equate for total length of the 
problem-solving task, several time gaps were programmed between the 
rapidly paced subset of problems. 
Pain Tolerance Test 
Pain was induced with the cold-pressor procedure. Two insulated 
containers were used in the tests of pain tolerance. One container filled 
with water kept at 20 *C was used prior to each cold-pressor test. The 
other container was divided into two compartments by a wire screen, 
with ice in one side and ice-free water in the other. The water was circu- 
lated by a submerged pump and maintained at a constant temperature 
of 0 *C. 
Subjects were instructed to place their dominantly preferred hand in 
the 20 *C water for 2 rain to equalize initial hand temperatures. They 
were then asked to immerse their hand in the ice water up to the wrist 
for as long as they could. The pain tolerance score was the number of 
seconds subjects were able to keep their hands in the ice water. In the 
drug phase of the study, the maximum time allowed for each cold-pres- 
sor test was 5 rain. All the cold-pressor pain tests were administered by 
a female experimenter. 
Efficacy Induction Procedure 
In the next step of the experiment, subjects performed the mathemat- 
ical problem-solving task under conditions designed to create high and 
low perceived controlling efficacy. All the instructions and the cognitive 
task demands were presented on a computer monitor following a pro- 
grammed procedure. 
To eliminate any possible social bias, the female experimenter initi- 
Perceived Mathematical Self-Efficacy 
The instructional part of the computer program instructed subjects 
to complete the mathematical self-efficacy scale before and after the 
mathematical problem-solving session. The self-efficacy scale included 
10 levels of performance attainments that ranged from solving 10% to 
100% of the problems. Subjects rated the strength of their self-judged 
efficacy that they could achieve each of the levels of mathematical at- 
tainment by using a 100-point scale ranging in 10-unit intervals from 
high uncertainty, through intermediate levels of certainty, to complete 
certitude. The measure of perceived mathematical self-efficacy was ob- 
tained by dividing the summed magnitude scores by the total number 
of items. 
The treatment conditions were highly effective in instating high and 
low levels of perceived self-efficacy. In only two instances did subjects' 
perceived self-efficacy diverge from the induction conditions. One sub- 
ject in the low controllability condition registered high perceived self- 
efficacy (83 strength), and one in the high controllability condition regis- 
tered very low perceived self-efficacy (39 strength), despite having solved 
92% of the mathematical problems. As this study is concerned with the 
opioid activation effects of perceived self-efficacy, the latter subjects were 
assigned to the high and low perceived self-efficacy groups, respectively. 
The mean strength of perceived mathematical self-efficacy was 23 for 
subjects in the low efficacy group, and 87 in the high efficacy group. 
This marked difference in perceived self-efficacy is highly significant, 
t(38) = 14.23,p < .0001. 
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Naloxone Intervention 
Because of its capacity to counteract the analgesic effect of opiates by 
blocking opiate receptors, naloxone is widely used to detect endogenous 
opioid activity. To test for opioid activation, half the subjects in each 
perceived self-efficacy group received an intravenous injection of 10 nag 
of naloxone, an opiate antagonist. Previous studies have shown that this 
high dosage of naloxone produces complete opioid blockage (Levine & 
Gordon, 1984). The other half of the subjects were given an injection of 
saline solution. 
The subjects were informed at the outset of the experiment that they 
would receive an injection of either an inactive medication or a sub- 
stance that may affect the physical mechanism controlling pain but that 
the individual effects on the experience of pain were not yet fully known. 
A nurse administered the injections under a double-blind procedure. 
Neither the nurse nor the tester knew whether the subjects received nal- 
oxone or saline. 
Postinjection Tests 
The experimenter administered pain tolerance tests at 5, 15, and 30 
min after the injection. Levine and his associates (Levine, Gordon, 
Jones, & Fields, 1978) have found that naloxone's antagonistic effects 
do not become evident until after 5 min. This temporal effect is corrob- 
orated by previous research on cold-pressor pain (Bendura ct al., 1987). 
Postexperiment Questionnaire 
At the conclusion of the experiment, subjects rated the level of stress 
and time pressure they experienced during the mathematical task, and 
the percent of their errors they judged were due to the pressure of the 
cognitive demands. These ratings were made on 10-point scales. At the 
end of the session, subjects were given a full explanation of the nature 
and purpose of the study. 
Resul ts  
Analyses of  variance (ANOVAS) performed on the pretest 
scores revealed that the groups did not differ initially on any of  
the measures of  perceived self-efficacy, pain tolerance, or level 
of  heart rate. Nor were there any significant sex differences in 
percentage change as a function of  treatment on any of  the mea- 
sures. 
Changes in Perceived Mathematical Self-Efficacy 
At the outset, subjects registered a moderately strong sense of 
mathematical self-efficacy (67 strength). However, after coping 
with the task demands, subjects in the low self-efficacy group 
experienced a marked decline in perceived self-efficacy, t(l 9) = 
9.91, p < .0001, whereas those in the high self-efficacy group 
heightened their sense of  mathematical self-efficacy, t(19) = 
3.67, p < .001. These differential changes in self-judged efficacy, 
which are plotted in Figure 1, are highly significant, t(38) = 
8.49, p < .0001. 
Level of Subjective Stress 
Figure 2 summarizes the mean levels in subjective stress and 
stress-induced performance impairment reported by subjects 
in the high and low perceived self-efficacy groups. 
Compared with the self-efficacious subjects, the self-ineffi- 
Figure 1. Magnitude of change in perceived mathematical self-efficacy 
exhibited by subjects in the perceived self-efficacious and perceived self- 
inefficacious conditions. 
cacious ones reported experiencing more than twice as much 
stress, t(38) = 7.09, p < .0001, and considerably more mental 
strain from time pressure, t(38) = 10.32, p < .0001. They also 
perceived a markedly higher stress-induced impairment of  their 
mathematical problem-solving, t(38) = 10.38, p < .0001. 
Heart Rate Changes 
In Figure 3 are plotted the mean percent changes in heart rate 
in beats per minute (bpm) from baseline at different phases of  
the problem-solving task of  subjects in the high and low per- 
ceived self-efficacy groups. The data are plotted over 2-rain in- 
tervals. Because of  an equipment malfunction, the data for 2 
subjects in the high efficacy condition are missing. The intimi- 
dation of  a medical setting with all its concomitant parapherna- 
lia, together with anticipations of  tests of  cognitive capabilities, 
pain tolerance tests, drug injections, and blood draws under- 
standably elicited an initial heightened heart rate that averaged 
84 bpm in the total sample during the baseline period. As pre- 
viously noted, the high and low perceived mathematical self- 
efficacy groups did not differ in heart rate in the baseline period, 
which preceded the instructions for the computational task. 
The subsequent course of  autonomic arousal was differentially 
affected by perceived coping self-efficacy. 
The two efficacy groups were comparable during the period 
when they received instructions for the mathematical task. 
However, they diverged substantially while coping with the 
mathematical problems, especially during the first third of  the 
task. An ANOVA was performed on the heart-rate data with per- 
ceived self-efficacy and time interval as the factors. The analysis 
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Figure 2. Level of subjective stress, mental strain from time pressure, and perceived stress-induced impair- 
ment in mathematical problem-solving reported by subjects in the perceived self-efficacious and perceived 
self-inefficacious conditions. 
revealed a significant interaction, F(10, 360) = 1.92, p < .04. 
The perceived self-inefficacious subjects exhibited a higher 
heart rate than their perceived self-efficacious counterparts dur- 
ing the first 2-min interval, t(36) = 1.87, p < .04, and the third 
2-min period, t(36) = 1.5 l , p  < .07. Although the perceived self- 
inefficacious subjects also continued to exhibit a higher heart 
rate at all the subsequent time points, the differences fell short 
of  statistical significance. 
The differences in heart rate between the two groups again 
became highly pronounced at the end of the task when subjects 
were rating their perceived mathematical self-efficacy. Perceived 
self-inefficacious subjects showed a heightened heart rate, 
whereas the perceived self-efficacious ones displayed a marked 
decline in heart rate. These opposite directional changes are 
highly significant, t(36) = 1.97, p < .03. 
Heart rate was significantly related to perceived mathemati- 
cal self-efficacy. For the perceived self-inefficacious subjects, the 
weaker their perceived self-efficacy following the computational 
task, the more elevated was their heart rate. This was true for 
the first 2 min of  the computational task, r(18) = .47, p < .02; 
the first third of  the task when the elevation was most evident, 
r ( l  8) = .47, p < .02; and for the entire duration of the computa- 
tional activity, r(18) = .45, p < .03. The greater the decline in 
perceived self-efficacy, the more elevated was their heart rate 
during the first 2 min, r(18) = .33, p < .08, and the first third 
of  the computational task, r(18) = .30, p < .  10. 
The perceived self-efficacious subjects exhibited a uniformly 
high sense of efficacy following the computational task. Even 
within the limited variance at this upper level of  efficacy, the 
weaker the perceived self-efficacy, the higher the heart rate dur- 
ing the first third of  the task, r(16) = .38, p < .06. The more 
subjects increased their perceived self-efficacy, the greater was 
the decline in their heart rate at 2 min, r(16) = - .35 ,  p < .08, 
and the first third of the task, r(16) = - .37 ,  p < .07. Moreover, 
the stronger the subjects' perceived self-efficacy, the greater the 
reduction they experienced in heart rate when they judged their 
self-efficacy after the computational task had been completed, 
r(16) = .52, p < .02. 
Test for Opioid Activation 
The changes exhibited under different drug conditions by 
perceived self-efficacious and self-inefficacious subjects were 
evaluated in terms of  percentage change in pain tolerance from 
the preinjection baseline level. This measure was used because 
it controls for individual differences in initial ability to with- 
stand pain and has been shown to be more sensitive to treatment 
influences than are simple difference scores (Hilgard et al., 
1974). 
Variances in pain tolerance were significantly much larger 
under saline than under naloxone conditions at each of  the tests 
of pain tolerance. Several extreme responders produced highly 
skewed distributions. Hence, nonparametric tests were used to 
test for naloxone antagonistic effects. Figure 4 presents the me- 
dian changes in pain tolerance at the three postinjection tests 
as a function of perceived self-efficacy and drug administration. 
Opioid activity is indicated if subjects who had been given nal- 
oxone are less able to endure pain stimulation than those given 
saline. 
High perceived self-efficacy To evaluate intragroup changes, 
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Figure 3. Percentage changes in heart rate displayed by perceived self-efficacious and perceived self-ineffi- 
cacious subjects while they received instructions for the task (INST.), coped with the mathematical task 
demands, and rated their perceived mathematical self-efficacy at the completion of the task. (Each data 
point in the problem-solving phase represents the mean heart rate [bpm] over a 2-rain interval for a total 
of 18 min.) 
Friedman two-way ANOVAs were performed separately on the 
scores for the saline and naloxone subgroups across the four 
tests of pain tolerance. For the highly self-efficacious subjects, 
neither the fluctuations in pain tolerance under naloxone, 
• = 3.00, nor the rise under saline, • = 4.11, was sig- 
nificant. 
Evaluation of  intergroup differences by the Mann-Whitney 
test showed that highly self-efficacious subjects administered 
naloxone did not differ significantly in pain tolerance from 
those given saline at any of  the three postinjection tests. Thus, 
subjects who judged themselves highly efficacious in coping 
with cognitive task demands showed no evidence of  opioid acti- 
vation. 
Low perceived self-efficacy. Perceived self-inefficacious sub- 
jects, who were stressed by their inability to fulfill cognitive de- 
mands, displayed a uniformly low level of  pain tolerance under 
naloxone (Figure 4). In marked contrast, self-inefficacious sub- 
jects administered saline achieved a substantial rise in pain tol- 
erance, • = 9.60, p < .03. Pairwise comparisons were per- 
formed with the Wilcoxon test between the levels of  pain toler- 
ance at the four data points to identify the significant changes. 
Compared with their baseline level, self-inefficacious saline 
subjects were better able to tolerate painful stimulation at both 
the 15-rain test, z = 2.50, p < .02, and the 30-min test, z = 
2.09, p < .04. They were also able to tolerate much more pain 
stimulation both at the 15-min test, z = 2.09, p < .04, and the 
30-rain test, z = 1.99, p < .05, than at the 5-rain point. 
The divergent tolerances of  painful stimulation by self-in- 
efficacious subjects under drug and saline conditions are sig- 
nificant at the points at which the opioid antagonistic effects of  
naloxone should become most evident. The groups did not 
differ at the 5-rain test. However, perceived self-inefficacious 
subjects administered naloxone were much less tolerant of  pain 
than their saline counterparts at the 15-min test, U = 25, p < 
.03, and at the 30-rain test, U = 24, p < .03. 
Heightening pain sensitivity by opioid blockage would atten- 
uate pain tolerance under all conditions and, indeed, the two 
naloxone groups did not differ in this respect. Self-inefficacious 
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Figure 4. Percentage change in pain tolerance as a function of perceived self-efficacy to exercise control 
over mathematical task demands and whether the subjects have received saline or the opiate antagonist, 
naloxone. 
saline subjects increasingly surpassed their self-efficacious sa- 
line counterparts on successive cold-pressor tests. However, sev- 
eral subjects in the latter group displayed sizable increases in 
pain tolerance so that the intergroup differences fell short of 
significance. The predictors of  pain tolerance under different 
conditions, which are considered next, reveal interesting re- 
lations that help to explain these increases. 
Pain Control Self-Efficacy and Pain Tolerance 
Pain endurance self-efficacy. Subjects' perceived self-efficacy 
to withstand pain measured before their baseline assessment 
predicted their level of  pain tolerance in both the subsequent 
baseline test, r(38) = .47, p < .001, and the postinjeetion tests. 
As the correlations at the different postinjection tests were of  
comparable magnitude, they were averaged by means of  an r 
to z transformation. The stronger the subjects' perceived self- 
efficacy to withstand pain, the longer they tolerated the painful 
stimulation in the succeeding cold-pressor tests. However, per- 
ceived self-efficacy was more strongly related to pain tolerance 
under saline conditions, r(l 8) = .65, p < .001, than under nal- 
oxone antagonistic conditions, r(l 8) --- .35, p < .07. 
Pain reduction self-efficac~ Subjects' initial baseline per- 
ceived self-efficacy to reduce experienced pain did not predict 
pain tolerance for the total sample. However, the mathemati- 
cally self-inefficacious subjects given saline, whose pain sensitiv- 
ity was apparently blunted by opioid activity, were able to trans- 
late their perceived pain-reductive capabilities into pain-toler- 
ant behavior. The stronger their perceived self-efficacy at the 
outset to reduce pain, the longer they endured painful stimula- 
tion in the postinjection tests, r(8) = .55, p < .05. Their low 
mathematical self-efficacy counterparts, who received the opi- 
ate antagonist, exhibited a negative, although nonsignificant, 
relation between perceived pain-reductive efficacy and level of  
pain tolerance, r(8) = - .27.  
For the mathematical self-efficacious subgroups, the corre- 
lations between pain reduction self-efficacy at baseline and pain 
tolerance in the postinjection tests were r(8) = .46, p < .  10, 
under saline treatment, and r(8) = - .10,  ns, under naloxone 
treatment. 
Impairment of  Mathematical Self-Efficacy and Pain 
Tolerance 
The powerful efficacy induction produced subgroups that 
differed markedly in mathematical self-perceived efficacy and 
stress, with minimal variance within the subgroups. The se- 
verely curtailed range of scores for these variables precluded 
any meaningful correlational analysis. However, one of  the vari- 
ables that has bearing on stressfulness of  the cognitive task pro- 
vided a wider variation of  scores for correlational analysis. This 
variable is the percentage impairment in subjects' perceived 
mathematical self-efficacy as calculated from their self-judged 
efficacy before and after the computational task. 
The subgroup combining perceived self-inefficacy with the 
saline treatment yielded a moderately high correlation between 
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magnitude of self-efficacy impairment and pain tolerance. The 
greater the loss subjects suffered in perceived mathematical self- 
efficacy, the longer they were able to endure pain in the postin- 
jection tests, r(8) = .57, p < .05. In sharp contrast, self-efficacy 
impairment had a strong opposite effect under conditions in 
which endogenous opioid mechanisms were controlled by nal- 
oxone. The more subjects suffered impairment in their per- 
ceived mathematical self-efficacy, the less able they were to bear 
pain, r(8) = -.59, p < .04. 
Although self-efficacious subjects did not significantly alter 
their pain tolerance under saline treatment, the degree of 
change in their perceived mathematical self-efficacy accounted 
for a large portion of the variance in pain tolerance exhibited 
by this subgroup. The more they raised their perceived mathe- 
matical self-efficacy, the better they tolerated painful stimula- 
tion, r(8) = .84, p < .01 (two-tailed test). However, for the self- 
efficacious subgroup given naloxone, gains in perceived mathe- 
matical self-efficacy were unrelated to pain tolerance. 
Changes in Heart Rate and Pain Tolerance 
Under conditions of opioid blockage by naloxone, no re- 
lations were expected between changes in autonomic arousal 
and pain tolerance, and none were found. However, some posi- 
tive relations were obtained between these variables under sa- 
line conditions. The higher the heart rate elevation relative to 
baseline level, the greater was the increase in pain tolerance at 
the 30-min test. These relations are r(16) = .36, p < .07, for 
elevated arousal during the first 2 min of the computational 
task, and r(16) = .36, p < .07, for arousal in the first third of 
the task. 
Discusfion 
The results of the present experiment provide evidence that 
perceived self-efficacy in coping with cognitive stressors acti- 
vates endogenous opioid systems. Perceived coping inefficacy 
was highly stressful and autonomically arousing. Subjects who 
perceived themselves as unable to exercise control over cogni- 
tive demands experienced a high level of stress, mental strain, 
and perceived impairment in cognitive functioning. In sharp 
contrast, subjects who had developed a strong sense of control- 
ling efficacy were relatively unperturbed by the cognitive task. 
Perceived coping inefficacy not only activated higher auto- 
nomic arousal during the problem-solving, but left subjects in 
a sensitized inefficacious state that persisted beyond the task. 
Thus, when simply asked to judge their capabilities after the 
cognitive task was over, the perceived self-inefficacious subjects 
displayed a heightened autonomic arousal, whereas the per- 
ceived self-efficacious ones exhibited a marked drop in auto- 
nomic arousal. The autonomic reductive effects of perceived 
self-efficacy are especially striking. Stress reactions can be cog- 
nitively activated by self-referent thought (Bandura, 1986). Be- 
cause of this capacity for cognitive self-activation, arousal does 
not simply dissipate with the termination of the stressor. The 
empty intervals between cold-pressor tests provided ample op- 
portunities for cognitive reactivation of divergent levels of auto- 
nomic arousal. 
Naloxone and saline treatments had substantially different 
effects on the self-inefficacious stressed groups and the self- 
efficacious nonstressed groups. Subjects who had a strong sense 
of controlling efficacy were not sufficiently stressed to activate 
endogenous opioids to block pain transmission. Their pain tol- 
erance did not change significantly across repeated cold-pressor 
tests under either saline or naloxone treatments. The lack of any 
differences in toleration of pain stimulation between saline and 
naloxone subgroups of self-efficacious subjects indicates an ab- 
sence of opioid activity in self-efficacious nonstressed subjects. 
In contrast, the self-inefficacious stressed subjects were able 
to withstand increasing amounts of pain stimulation under sa- 
line conditions. However, when the endogenous opioid mecha- 
nisms that control pain were blocked by naloxone, the subjects 
were unable to bear much pain stimulation. This pattern of 
changes suggests that the stress-induced analgesia found under 
the saline condition was mediated by endogenous opioid mech- 
anisms and counteracted by the opiate antagonist. In accord 
with previous findings, the naloxone antagonistic effect became 
evident after sufficient time had elapsed for the drug to exert its 
effects (Bandura et al., 1987; Levine et al., 1978). 
Experience of controllability produced substantial cognitive 
changes in perceived self-efficacy. Thereafter, mere self-ap- 
praisal of coping capabilities autonomically aroused the per- 
ceived self-inefficacious subjects, but calmed the perceived self- 
efficacious ones. These different stress reactions suggest that, 
after self-efficacy beliefs are instilled, simply approaching envi- 
ronmental demands in a self-inefficacious frame of mind may 
produce some opioid activation anticipatorily. Any reductions 
in pain sensitivity could make coping with aversive situations 
easier. Preparatory opioid activation by self-inefficacious 
thought remains a significant problem to be investigated. 
Initial strength of perceived self-efficacy to endure pain pre- 
dicted how well subjects managed subsequent pain stimulation. 
The stronger their beliefs in their ability to withstand pain, the 
longer they endured mounting pain under all treatment condi- 
tions. These findings are in accord with several lines of evidence 
supporting the positive role of perceived self-regulatory efficacy 
in coping with acute pain (Bandura, in press; Litt, 1988; Man- 
ning & Wright, 1983; Vallis & Bucher, 1986) and with chronic 
clinical pain (Holroyd et al., 1984; O'Leary, Shoor, Lorig, & 
Holman, in press; Philips, 1987; Shoor & Holman, 1984). As 
might be expected, perceived self-efficacy exercised weaker pain 
control under conditions in which sensitivity to painful stimula- 
tion was increased by blockage of endogenous opioid mecha- 
nisms. It is much more difficult to translate self-efficacy belief 
into pain-tolerating behavior in a physical state of heightened 
pain sensitivity. 
Perceived self-efficacy to effect reductions in experienced 
pain reflects a more active exercise of personal agency than does 
stoic endurance. Consideration of the contributions of pain 
control self-efficacy and cognitive self-efficacy to variance in 
pain tolerance under different perceived controllability and 
drug conditions reveals interesting patterns of results. As will 
be recalled, the perceived self-efficacious nonstressed subjects 
exhibited no significant changes in pain tolerance over the series 
of postinjection tests. However, the predictors of variance in 
pain tolerance for these subjects differs depending on whether 
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they received the saline or naloxone treatment. Variation in 
pain tolerance for those administered naloxone seemed to be 
due, in part, to force of  effort as reflected in the positive relation 
between belief in ability to endure pain and level of pain toler- 
ance. For the subjects administered the saline solution, the pre- 
dictors of  variance in pain tolerance were perceived self-efficacy 
to withstand pain as well as enhancement of  cognitive self- 
efficacy. Evidently, a boost in perceived self-efficacy in the cog- 
nitive domain was transferred to a more perseverant effort in 
the pain coping domain. 
The perceived self-inefficacious subjects who were adminis- 
tered the opiate antagonist were also unable to endure much 
pain. But the predictors of  their variance in pain tolerance differ 
in an important respect from their self-efficacious naloxone 
counterparts. Belief in efficacy to withstand pain and low im- 
pairment of  perceived cognitive self-efficacy presaged pain tol- 
erance. These correlates indicate reliance on forbearance and 
cognitive resilience in efforts to cope with pain sensations under 
the state of  heightened pain sensitivity. 
The substantial increase in pain tolerance achieved by self- 
inefficacious subjects administered saline seemed to rest on the 
stress of perceived cognitive impairment and active exercise of  
self-regulatory efficacy. With the blunting of  pain sensitivity by 
opiate activity, they could readily act on their perceived self- 
efficacy to withstand and reduce pain sensations. 
As noted, increased pain tolerance was predicted by per- 
ceived enhancement of  cognitive self-efficacy in self-efficacious 
saline subjects, but by perceived impairment of  cognitive self- 
efficacy in self-inefficacious saline subjects. These differential 
predictors may help to explain why these two groups did not 
show even greater divergence in pain tolerance. Among subjects 
in the self-efficacious saline group, those who experienced a siz- 
able boost in cognitive self-efficacy achieved notable increases 
in pain tolerance. This reduced intergroup differences. Mea- 
surement of  different possible determinants helps to clarify the 
sources of  variance and magnitude of change in pain tolerance 
under different efficacy and drug conditions. 
It is interesting to speculate on how the capacity of stressors 
to activate endogenous opioids evolved. In physically threaten- 
ing situations entailing fear and pain, it would be highly adap- 
tive to possess an opioid system to alleviate pain so that vigor- 
ous defense or speedy flight can be successfully executed. Stress- 
induced analgesia would clearly be advantageous in the struggle 
for physical survival. Indeed, Fanselow (1986) has shown that 
through paired experience with painful stimulation, danger sig- 
nals acquire the ability to a?tivate endogenous opioids that at- 
tenuate the aversiveness of  painful stimuli and facilitate defen- 
sive behavior. 
Modern-day struggles involve strenuous activities and pro- 
longed exposure to psychological stressors on athletic fields, in 
classrooms, in social circles, and in occupational settings. These 
stressors produce their own set of  aches, strains, pains, head- 
aches, and other physical discomforts. Success in difficult un- 
dertakings requires perseverant effort in the face of many stress- 
ful and aversive elements. To abort one's efforts prematurely 
because of  accompanying discomfort is self-limiting. People are 
better able to deal with stressful environmental demands if not 
beset by pain. Thus, for example, opioid reduction of pain sen- 
sitivity in exercise stress helps athletes to achieve high perfor- 
mances that they might otherwise forsake (Janal, Colt, Clark, 
& Glusman, 1984). An endogenous mechanism that enables 
people to handle stressful situations with some relief from phys- 
ical aversiveness has some advantageous functions. 
Benefits rarely come devoid of  costs. A growing body of  evi- 
dence reveals that the stress of  coping inefficacy not only acti- 
vates endogenous opioids, but also impairs cellular components 
of  the immune system (Kiecolt-Glaser & Glaser, 1988; Maier et 
al., 1985; Shavit & Martin, 1987). Prolonged impairment of  the 
immune function increases vulnerability to infection. Physio- 
logical systems are highly interdependent. There is evidence 
that some of  the immunosuppressive effects of  inefficacy in con- 
trolling stressors are mediated by release of  endogenous opioids 
(Shavit & Martin, 1987). When opioid mechanisms are blocked 
by naloxone, the stress of  coping inefficacy loses its immuno- 
suppressive capabilities. Thus, the benefits of  reduced pain sen- 
sitivity may be gained at the cost ofimmunocompetence. 
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